- Home
- BLSH vs TECH Comparison
BLSH vs TECH Comparison
Compare BLSH & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLSH
- TECH
- Stock Information
- Founded
- BLSH 2020
- TECH 1976
- Country
- BLSH Cayman Islands
- TECH United States
- Employees
- BLSH N/A
- TECH N/A
- Industry
- BLSH Finance: Consumer Services
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLSH Finance
- TECH Health Care
- Exchange
- BLSH Nasdaq
- TECH Nasdaq
- Market Cap
- BLSH 10.2B
- TECH 8.2B
- IPO Year
- BLSH 2025
- TECH 1989
- Fundamental
- Price
- BLSH $64.89
- TECH $62.95
- Analyst Decision
- BLSH Buy
- TECH Buy
- Analyst Count
- BLSH 11
- TECH 12
- Target Price
- BLSH $56.90
- TECH $70.91
- AVG Volume (30 Days)
- BLSH 4.9M
- TECH 2.9M
- Earning Date
- BLSH 09-17-2025
- TECH 10-29-2025
- Dividend Yield
- BLSH N/A
- TECH 0.51%
- EPS Growth
- BLSH N/A
- TECH N/A
- EPS
- BLSH N/A
- TECH 0.46
- Revenue
- BLSH $259,164,241,000.00
- TECH $1,219,635,000.00
- Revenue This Year
- BLSH N/A
- TECH $3.97
- Revenue Next Year
- BLSH $29.61
- TECH $7.81
- P/E Ratio
- BLSH N/A
- TECH $136.85
- Revenue Growth
- BLSH 255.53
- TECH 5.23
- 52 Week Low
- BLSH $47.88
- TECH $46.01
- 52 Week High
- BLSH $118.00
- TECH $80.80
- Technical
- Relative Strength Index (RSI)
- BLSH N/A
- TECH 73.87
- Support Level
- BLSH N/A
- TECH $50.13
- Resistance Level
- BLSH N/A
- TECH $54.57
- Average True Range (ATR)
- BLSH 0.00
- TECH 2.24
- MACD
- BLSH 0.00
- TECH 1.25
- Stochastic Oscillator
- BLSH 0.00
- TECH 93.30
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.